4 completed, 1 not yet recruiting, 1 withdrawn. 3 Phase 3, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Not yet recruiting 1 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 4 | 1 | Completed 1 |
Follow Vaccines, Attenuated: new trials by email Literature Review of Vaccines, Attenuated trials Research Report on Vaccines, Attenuated
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial to Evaluate the Immunogenicity and Safety of the Co-administration of Live Attenuated Dengue and Chikungunya Vaccines Compared to Separate Administration in Adults Aged 18 to 59 Years. DENGUE: Dengue 1,2,3,4 (attenuated) vaccine CHIKUNGUNYA: Chikungunya (CHIKV) live attenuated vaccine (VLA1555), DENGUE: Dengue 1,2,3,4 (attenuated) vaccine, Chikungunya (CHIKV) live attenuated vaccine (VLA1555) - Dengue, Chikungunya | Phase 3 | Not yet recruiting | Butantan Institute | 900 | 2027-03-31 | 2026-07-16 |
| ROTA-biotic: Measuring the Impact of Rotavirus Vaccines on Paediatric Antibiotic Usage Vaccine - Rotavirus Gastroenteritis, Rotavirus Vaccines | Completed | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1600 | 2021-05-04 | 2025-03-18 | |
| TDENV PIV and LAV Dengue Prime-boost Strategy Using AS03B Adjuvant TDENV-PIV, TDENV-F17, Placebo - Dengue | Phase 1 | Withdrawn | U.S. Army Medical Research and Development Command | 2016-01-01 | 2017-04-12 | |
| Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases Measles, Mumps, Rubella and Chickenpox (live vaccine) - Measles, Rubella | Phase 3 | Completed | GlaxoSmithKline | 2005-11-01 | 2016-09-26 | |
| Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases Measles, Mumps, Rubella and Chickenpox (live vaccine) - Mumps, Varicella | Phase 3 | Completed | GlaxoSmithKline | 944 | 2005-05-01 | 2016-09-21 |
| Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases Measles, Mumps, Rubella and Chickenpox (live vaccine) - Mumps, Rubella | Phase 4 | Completed | GlaxoSmithKline | 1439 | 2005-05-01 | 2016-09-21 |
Chickenpox (3) · Measles (3) · Mumps (3) · Rubella (3) · Dengue (2) · Chikungunya Fever (1) · Diarrhea, Infantile (1)
GlaxoSmithKline (3) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Butantan Institute (1) · U.S. Army Medical Research and Development Command (1)
Germany (3) · Belgium (1) · Brazil (1) · Finland (1) · Ghana (1) · Greece (1) · Netherlands (1) · Poland (1) · United States (1) · Zambia (1)
Mark Polhemus (1)
PMID 32220283, PMID 32497524, PMID 37321235, PMID 38294972, PMID 39116904, PMID 39255380